FDA Struggles To Foster An Affordable Biosimilar Insulin
There is widespread medical need for insulin products — insulin is listed on the World Health Organization's model list of essential medicines — but there is little market competition. Eli Lilly...To view the full article, register now.
Already a subscriber? Click here to view full article